These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 26727623

  • 1. Expression of p53 in endometrial polyps with special reference to the p53 signature.
    Sho T, Hachisuga T, Kawagoe T, Urabe R, Kurita T, Kagami S, Shimajiri S, Fujino Y.
    Histol Histopathol; 2016 Jul; 31(7):751-8. PubMed ID: 26727623
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Overexpression of p53 in the endometrial gland in postmenopausal women.
    Koi C, Hachisuga T, Murakami M, Kurita T, Nguyen TT, Shimajiri S, Fujino Y.
    Menopause; 2015 Jan; 22(1):104-7. PubMed ID: 24893067
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
    Hosoda M, Yamamoto M, Nakano K, Hatanaka KC, Takakuwa E, Hatanaka Y, Matsuno Y, Yamashita H.
    Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
    [Abstract] [Full Text] [Related]

  • 6. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
    Giordano G, Gnetti L, Merisio C, Melpignano M.
    Maturitas; 2007 Feb 20; 56(2):190-7. PubMed ID: 16963204
    [Abstract] [Full Text] [Related]

  • 7. Proliferation in Postmenopausal Endometrial Polyps-A Potential for Malignant Transformation.
    Adomaitienė L, Nadišauskienė R, Nickkho-Amiry M, Čižauskas A, Palubinskienė J, Holland C, Seif MW.
    Medicina (Kaunas); 2019 Aug 28; 55(9):. PubMed ID: 31466367
    [Abstract] [Full Text] [Related]

  • 8. Effect of menopause on hormonal receptors in ampullae of the fallopian tube with a special reference to the p53 signature.
    Urabe R, Hachisuga T, Ueda T, Kawagoe T, Kurita T, Kagami S, Hisaoka M, Fujino Y.
    Int J Womens Health; 2017 Aug 28; 9():163-169. PubMed ID: 28435327
    [Abstract] [Full Text] [Related]

  • 9. Expression of immunoreactivity and genetic mutation in eosinophilic and ciliated metaplastic changes of endometrial glandular and stromal breakdown: cytodiagnostic implications.
    Shimizu K, Norimatsu Y, Kobayashi TK, Sakurai M, Ogura S, Yoshizawa A, Miyamoto T, Miyake Y, Aratake Y, Sakaguchi T, Ohno E.
    Ann Diagn Pathol; 2009 Apr 28; 13(2):89-95. PubMed ID: 19302956
    [Abstract] [Full Text] [Related]

  • 10. Is the immunohistochemical expression of proliferation (Ki-67) and apoptosis (Bcl-2) markers and cyclooxigenase-2 (COX-2) related to carcinogenesis in postmenopausal endometrial polyps?
    Antunes A, Andrade LA, Pinto GA, Leão R, Pinto-Neto AM, Costa-Paiva L.
    Anal Quant Cytopathol Histpathol; 2012 Oct 28; 34(5):264-72. PubMed ID: 23301386
    [Abstract] [Full Text] [Related]

  • 11. Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma.
    Jarboe EA, Pizer ES, Miron A, Monte N, Mutter GL, Crum CP.
    Mod Pathol; 2009 Mar 28; 22(3):345-50. PubMed ID: 19151662
    [Abstract] [Full Text] [Related]

  • 12. [Expression of p53, Ki-67, bcl-2, c-erb-2, estrogen, and progesterone receptors in endometrial cancer].
    Pilka R, Mícková I, Lubuský M, Dusková M, Rícánková M, Kudela M.
    Ceska Gynekol; 2008 Jul 28; 73(4):222-7. PubMed ID: 18711961
    [Abstract] [Full Text] [Related]

  • 13. Spontaneous programmed cell death in infiltrating duct carcinoma: association with p53, BCL-2, hormone receptors and tumor proliferation.
    Pillai MR, Kesari AL, Chellam VG, Madhavan J, Nair P, Nair MK.
    Pathol Res Pract; 1998 Jul 28; 194(8):549-57. PubMed ID: 9779489
    [Abstract] [Full Text] [Related]

  • 14. A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma.
    Oreskovic S, Babic D, Kalafatic D, Barisic D, Beketic-Oreskovic L.
    Gynecol Oncol; 2004 Apr 28; 93(1):34-40. PubMed ID: 15047211
    [Abstract] [Full Text] [Related]

  • 15. P53 and Murine Double Mimute 2 (MDM2) Expression Changes and Significance in Different Types of Endometrial Lesions.
    Jiang Z, Xu W, Dan G, Liu Y, Xiong J.
    Med Sci Monit; 2016 Dec 07; 22():4786-4793. PubMed ID: 27924072
    [Abstract] [Full Text] [Related]

  • 16. Clinical implications and prognostic value of single and combined biomarkers in endometrial carcinoma.
    Li M, Zhao L, Shen D, Li X, Wang J, Wei L.
    Chin Med J (Engl); 2014 Dec 07; 127(8):1459-63. PubMed ID: 24762589
    [Abstract] [Full Text] [Related]

  • 17. Aging and uterine serous carcinoma.
    Hachisuga T.
    Histol Histopathol; 2018 Nov 07; 33(11):1125-1133. PubMed ID: 29565096
    [Abstract] [Full Text] [Related]

  • 18. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2.
    Nagao T, Sugano I, Ishida Y, Hasegawa M, Matsuzaki O, Konno A, Kondo Y, Nagao K.
    Cancer; 1998 Feb 01; 82(3):439-47. PubMed ID: 9452259
    [Abstract] [Full Text] [Related]

  • 19. Endometrial polyps in obese asymptomatic pre and postmenopausal patients with breast cancer: is screening necessary?
    Lubián López DM, Orihuela López F, García-Berbel Molina L, Boza Novo P, Pozuelo Solís E, Menor Almagro D, Comino Delgado R.
    Gynecol Oncol; 2014 Apr 01; 133(1):56-62. PubMed ID: 24680592
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.